Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) patients who developed BACK PAIN.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) reported BACK PAIN to the FDA. A total of 1 BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) and BACK PAIN. In doing so, we compare BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) with other drugs that cause BACK PAIN, to help you evaluate whether or not BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) causes BACK PAIN. Likewise, this page shows the most highly-reported side effects of BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE), so you can see if BACK PAIN ranks among BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE)'s most well-known side effects.
Summary Statistics
Reports of BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) causing BACK PAIN: 1
Reports of any side effect of BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) : 1
Percentage of BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) patients where BACK PAIN is a reported side effect: 100.0000%

FDA reports of any drug causing BACK PAIN : 63655
Average percentage for all medicated patients where BACK PAIN is reported as a complication: 0.3990%

Physician opinion on BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE):
( 0 patients )
Drugs with high FDA adverse event association with BACK PAIN:

FOSAMAX (10530 patients)
VIOXX (6233 patients)
ASPIRIN (5997 patients)
FORTEO (5274 patients)
ZOMETA (4875 patients)
LIPITOR (3450 patients)
SEROQUEL (3432 patients)
PREDNISONE (3019 patients)
ACCUTANE (2935 patients)
NEXIUM (2874 patients)
ENBREL (2847 patients)
HUMIRA (2824 patients)
AREDIA (2726 patients)
NEURONTIN (2513 patients)
SYNTHROID (2501 patients)
LISINOPRIL (2497 patients)
AVONEX (2420 patients)
LASIX (2340 patients)
PRILOSEC (2285 patients)
XANAX (2258 patients)
AMBIEN (2198 patients)
COUMADIN (2189 patients)
OXYCONTIN (2167 patients)
TYSABRI (2154 patients)
CELEBREX (2080 patients)
REMICADE (2049 patients)
VITAMIN D (1963 patients)
FOLIC ACID (1948 patients)
METHOTREXATE (1914 patients)
VICODIN (1882 patients)
LYRICA (1876 patients)
PROTONIX (1876 patients)
ATENOLOL (1866 patients)
ZOLOFT (1860 patients)
HYDROCHLOROTHIAZIDE (1840 patients)
OMEPRAZOLE (1823 patients)
ZOCOR (1798 patients)
PERCOCET (1771 patients)
LEVAQUIN (1711 patients)
PLAVIX (1684 patients)
DURAGESIC-100 (1647 patients)
FUROSEMIDE (1636 patients)
IBUPROFEN (1627 patients)
SIMVASTATIN (1617 patients)
ALBUTEROL (1600 patients)
NORVASC (1599 patients)
TOPROL-XL (1585 patients)
CRESTOR (1570 patients)
PREVACID (1532 patients)
CALCIUM (1520 patients)
DEXAMETHASONE (1509 patients)
ACETAMINOPHEN (1493 patients)
ATIVAN (1476 patients)
CYMBALTA (1421 patients)
GABAPENTIN (1418 patients)
LEXAPRO (1417 patients)
LORTAB (1387 patients)
SOLIRIS (1377 patients)
PAXIL (1373 patients)
LORAZEPAM (1365 patients)
DIGOXIN (1355 patients)
ZOFRAN (1340 patients)
POTASSIUM CHLORIDE (1340 patients)
MIRENA (1311 patients)
DECADRON (1305 patients)
OXYCODONE HCL (1265 patients)
PROZAC (1243 patients)
EFFEXOR (1222 patients)
DIOVAN (1203 patients)
LEVOTHYROXINE SODIUM (1202 patients)
PREMARIN (1194 patients)
BONIVA (1194 patients)
FLEXERIL (1173 patients)
MORPHINE (1170 patients)
HEPARIN SODIUM INJECTION (1138 patients)
SANDOSTATIN LAR (1136 patients)
METFORMIN HCL (1135 patients)
PREDNISONE TAB (1106 patients)
ALENDRONATE SODIUM (1082 patients)
KLONOPIN (1033 patients)
REVLIMID (1032 patients)
ADVAIR DISKUS 100/50 (1023 patients)
WELLBUTRIN (1021 patients)
ALPRAZOLAM (1013 patients)
MULTI-VITAMINS (1013 patients)
FOSAMAX PLUS D (990 patients)
ALLOPURINOL (987 patients)
DILAUDID (982 patients)
AMOXICILLIN (980 patients)
ACTONEL (972 patients)
WARFARIN SODIUM (968 patients)
CLONAZEPAM (955 patients)
SINGULAIR (948 patients)
LANTUS (947 patients)
CELEXA (946 patients)
NITROGLYCERIN (942 patients)
VALIUM (931 patients)
PREDNISOLONE (928 patients)
CHANTIX (922 patients)
DEFINITY (919 patients)
METOPROLOL TARTRATE (912 patients)
YAZ (912 patients)
YASMIN (904 patients)
BYETTA (889 patients)
ZANTAC (870 patients)
ZYRTEC (852 patients)
SPIRIVA (852 patients)
ARIMIDEX (829 patients)
DIAZEPAM (829 patients)
TAXOTERE (829 patients)
ALLEGRA (819 patients)
FENTANYL (818 patients)
CALCIUM CARBONATE (807 patients)
CHEMOTHERAPEUTICS NOS (789 patients)
MORPHINE SULFATE (786 patients)
REGLAN (779 patients)
COREG (774 patients)
TRAZODONE HCL (773 patients)
FEMARA (762 patients)
TRAMADOL HCL (760 patients)
GLUCOPHAGE (759 patients)
ZETIA (755 patients)
HYDROCODONE (744 patients)
FLOMAX (732 patients)
INSULIN (730 patients)
VITAMIN E (729 patients)
MOTRIN (727 patients)
TYLENOL (723 patients)
HYDROCODONE BITARTRATE (721 patients)
COLACE (721 patients)
TYLENOL (CAPLET) (720 patients)
EXJADE (717 patients)
FISH OIL (716 patients)
COMPAZINE (715 patients)
BENADRYL (715 patients)
ZYPREXA (714 patients)
SOMA (713 patients)
THALIDOMIDE (711 patients)
CIALIS (711 patients)
MULTI-VITAMIN (709 patients)
CIPROFLOXACIN (707 patients)
VITAMIN B-12 (700 patients)
LOVENOX (687 patients)
ULTRAM (674 patients)
METOPROLOL (673 patients)
ZITHROMAX (672 patients)
TAMOXIFEN CITRATE (668 patients)
RADIATION THERAPY (664 patients)
ASCORBIC ACID (664 patients)
NAPROXEN (659 patients)
PEPCID (653 patients)
ACTOS (651 patients)
ARANESP (651 patients)
AMLODIPINE (650 patients)
ELAVIL (649 patients)
COZAAR (644 patients)
ALEVE (CAPLET) (634 patients)
FLONASE (634 patients)
KEFLEX (629 patients)
CLONIDINE (629 patients)
LOPRESSOR (627 patients)
CLINDAMYCIN (625 patients)
AMITRIPTYLINE HCL (620 patients)
XELODA (616 patients)
REBIF (612 patients)
VELCADE (607 patients)
BACLOFEN (607 patients)
MIRALAX (593 patients)
RECLAST (592 patients)
PROMETHAZINE (586 patients)
TEMAZEPAM (584 patients)
AVELOX (584 patients)
MS CONTIN (583 patients)
CEPHALEXIN (573 patients)
[THERAPY UNSPECIFIED] (565 patients)
FLUCONAZOLE (565 patients)
CALCIUM (UNSPECIFIED) (561 patients)
SPIRONOLACTONE (558 patients)
ACYCLOVIR (555 patients)
SKELAXIN (551 patients)
GILENYA (540 patients)
RISPERDAL (540 patients)
CIPRO (538 patients)
PROLIA (537 patients)
FASLODEX (534 patients)
TAXOL (533 patients)
AVANDIA (527 patients)
BEXTRA (527 patients)
NIASPAN (527 patients)
GLIPIZIDE (522 patients)
OXYCODONE (518 patients)
LEVOXYL (512 patients)
AVASTIN (512 patients)
HUMALOG (508 patients)
IRON (506 patients)
METOCLOPRAMIDE (506 patients)
CLARITIN (505 patients)
PEGASYS (505 patients)
GLYBURIDE (504 patients)
POTASSIUM (501 patients)
NUVARING (496 patients)
ALEVE (496 patients)
ALTACE (496 patients)
MOBIC (491 patients)
CARBOPLATIN (490 patients)
VYTORIN (485 patients)
TOPAMAX (483 patients)
EVISTA (482 patients)
RANITIDINE (481 patients)
CYTOXAN (481 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE)


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about BACK PAIN and BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE), post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE), post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE). This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE) experts. If you are a healthcare provider experienced in prescribing BUTYLHYOSCINE (HYOSCINE BUTYLBROMIDE), please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use